Androgens May Mediate a Relative Preservation of IGF-I Levels in Overweight and Obese Women Despite Reduced Growth Hormone Secretion
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
CONTEXT: Obesity is characterized by reduced GH secretion, but data regarding IGF-I levels and their determinants are conflicting. OBJECTIVES: The objectives were to determine whether IGF-I levels are reduced and to investigate determinants of GH and IGF-I in healthy overweight and obese women. DESIGN: A cross-sectional study was performed. SETTING: The study was conducted at a General Clinical Research Center. STUDY PARTICIPANTS: Thirty-four healthy women without pituitary/hypothalamic disease participated, including 11 lean [body mass index (BMI) <25 kg/m(2)], 12 overweight (BMI > or =25 kg/m(2) and <30 kg/m(2)), and 11 obese (BMI > or =30 kg/m(2)) women of comparable age (overall mean age, 30.7 +/- 7.8 yr). INTERVENTION: There was no intervention. MAIN OUTCOME MEASURES: The main outcome measures were frequent sampling (every 10 min for 24 h) for GH, peak GH after GHRH-arginine stimulation, IGF-I, IGF binding protein-3, estrone, estradiol, testosterone, free testosterone, SHBG, homeostasis model assessment of insulin resistance, and abdominal fat. RESULTS: Mean 24-h GH and peak stimulated GH were lower in overweight than lean women and lowest in obese women. Mean IGF-I levels trended lower in obese, but not overweight, compared with lean women. Free testosterone was positively associated with IGF-I (R = 0.36, P = 0.04) but not with GH measures. Visceral fat was the only determinant of mean 24-h GH (R(2) = 0.66, P < 0.0001) and of peak stimulated GH (R(2) = 0.63, P < 0.0001), and mean 24-h GH accounted for 39% of the variability of IGF-I (P = 0.0002), with an additional 28% (P < 0.0001) attributable to free testosterone levels. CONCLUSIONS: Despite a linear decrease in GH secretion and peak stimulated GH levels with increasing BMI in healthy overweight and obese women, IGF-I levels were not commensurately reduced. Androgens may contribute to this relative preservation of IGF-I secretion in overweight and obese women despite reduced GH secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
WEISSBERGER, A. J., HO, K. K. Y., & LAZARUS, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-374 · Cited by 514
Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency
Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8509 · Cited by 423 · cited 1×
“GHRH (1 g/kg) plus arginine (0.5 g/kg; maximum, 30 g) was administered iv, and GH levels were drawn at baseline and every 30 min for 2 h. This test has been validated in comparison to the gold standard insulin tolerance test, with proposed cut-offs for the diagnosis of GH deficiency of 4.1 to 9 ng/ml ( 29 , 30).”
MethodInfluentialLukanova, A., Lundin, E., Zeleniuch-Jacquotte, A., Muti, P., Mure, A., Rinaldi, S., Dossus, L., Micheli, A., Arslan, A., Lenner, P., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500161 · Cited by 315 · cited 4×
“Our data do not suggest this to be the case because IGFBP-3 levels were not increased in overweight or obese women and were not positively associated with BMI, consistent with published data from other groups ( 9 , 11).”
BackgroundMethodResultInfluentialMiller, K. K., Rosner, W., Lee, H., Hier, J., Sesmilo, G., Schoenfeld, D., Neubauer, G., & Klibanski, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030680 · Cited by 301 · cited 1×
“Free testosterone was calculated from total testosterone and SHBG by the laws of mass action, which has been validated in comparison to free testosterone by equilibrium dialysis ( 33 ).”
MethodSelf-citationAimaretti, G., Corneli, G., Razzore, P., Bellone, S., Baffoni, C., Arvat, E., Camanni, F., & Ghigo, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4837 · Cited by 272
Weissberger, A. J., & Ho, K. K. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501143 · Cited by 185
Vahl, N., Jorgensen, J. O., Skjaerbaek, C., Veldhuis, J. D., Orskov, H., & Christiansen, J. S. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.6.e1108 · Cited by 178
Span, J. P. T., Pieters, G. F. F. M., Sweep, C. G. J., Hermus, A. R. M. M., & Smals, A. G. H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6463 · Cited by 132
Bondanelli, M., Ambrosio, M. R., Margutti, A., Franceschetti, P., Zatelli, M. C., & degli Uberti, E. C. (2003) · Neuroendocrinology · doi:10.1159/000071310 · Cited by 58
Research works printed but not linked: 42
- Copeland, 1990, The relationship between insulin-like growth factor-I, adiposity, and aging, Metabolism, 39, 584, 10.1016/0026-0495(90)90022-5 · DOI · Paper page
- Rasmussen, 1995, Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects., J Clin Endocrinol Metab, 80, 1407
- Yamamoto, 1993, Relationship between plasma insulin-like growth factor I (IGF-I) levels and body mass index (BMI) in adults., Endocr J, 40, 41, 10.1507/endocrj.40.41 · DOI
- Marin, 1993, Low concentrations of insulin-like growth factor-I in abdominal obesity., Int J Obes Relat Metab Disord, 17, 83
- Rasmussen, 2007, Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism., Obesity (Silver Spring), 15, 879, 10.1038/oby.2007.607 · DOI
- Gram, 2006, Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women., Int J Obes (Lond), 30, 1623, 10.1038/sj.ijo.0803324 · DOI
- Maccario, 1999, Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients., Int J Obes Relat Metab Disord, 23, 612, 10.1038/sj.ijo.0800889 · DOI
- Caufriez, 1984, Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects., Clin Endocrinol (Oxf), 20, 65, 10.1111/j.1365-2265.1984.tb00060.x · DOI
- Hochberg, 1992, The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa., Metabolism, 41, 106, 10.1016/0026-0495(92)90198-J · DOI · Paper page
- Nam, 1997, Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone., Int J Obes Relat Metab Disord, 21, 355, 10.1038/sj.ijo.0800412 · DOI · Paper page
- Clasey, 2001, Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors., J Clin Endocrinol Metab, 86, 3845, 10.1210/jcem.86.8.7731 · doi:10.1210/jcem.86.8.7731 · Paper page
- Vahl, 1996, Abdominal adiposity and physical fitness are major determinants of the age-associated decline in stimulated GH secretion in healthy adults., J Clin Endocrinol Metab, 81, 2209
- Rasmussen, 1994, The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone., Metabolism, 43, 315, 10.1016/0026-0495(94)90099-X · DOI
- Giusti, 1989, The effect of long-term pulsatile GnRH administration on the 24-hour integrated concentration of GH in hypogonadotropic hypogonadic patients., Acta Endocrinol (Copenh), 120, 724, 10.1530/acta.0.1200724 · DOI
- Liu, 1987, Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism., J Clin Endocrinol Metab, 64, 651, 10.1210/jcem-64-4-651 · DOI · Paper page
- Giustina, 1997, Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone., J Clin Endocrinol Metab, 82, 1210
- Keenan, 1993, Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty., J Clin Endocrinol Metab, 76, 996
- Loche, 1997, The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids., J Clin Endocrinol Metab, 82, 861
- Veldhuis, 2005, Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy., Eur J Endocrinol, 153, 577, 10.1530/eje.1.02001 · DOI · Paper page
- Gibney, 2005, Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men, Am J Physiol Endocrinol Metab, 289, E266, 10.1152/ajpendo.00483.2004 · DOI · Paper page
- Landin-Wilhelmsen, 2004, Insulin-like growth factor I levels in healthy adults, Horm Res, 62, 8
- Parkinson, 2001, The relationship between serum GH and serum IGF-I in acromegaly is gender-specific., J Clin Endocrinol Metab, 86, 5240, 10.1210/jcem.86.11.8006 · DOI
- Burman, 1997, Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women., J Clin Endocrinol Metab, 82, 550
- Utz, 2008, Growth hormone deficiency by GHRH/arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women., J Clin Endocrinol Metab, 93, 2507, 10.1210/jc.2008-0169 · DOI
- Koutkia, 2004, Growth hormone-releasing hormone in HIV-infected men with lipodystrophy., JAMA, 292, 210, 10.1001/jama.292.2.210 · DOI · Paper page
- Eden Engstrom, 2006, Effects of gastric bypass on the GH/IGF-I axis in severe obesity—and a comparison with GH deficiency., Eur J Endocrinol, 154, 53, 10.1530/eje.1.02069 · DOI
- Valera Mora, 2007, Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery., Obesity (Silver Spring), 15, 2012, 10.1038/oby.2007.240 · DOI
- De Marinis, 2004, Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition., J Clin Endocrinol Metab, 89, 174, 10.1210/jc.2002-021308 · DOI · Paper page
- Lukanova, 2002, Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)., Cancer Causes Control, 13, 509, 10.1023/A:1016392129279 · DOI
- Bednarek-Tupikowska, 2008, The correlations between endogenous dehydroepiandrosterone sulfate and some atherosclerosis risk factors in premenopausal women, Med Sci Monit, 14, CR37
- Maccario, 1999, Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women., Clin Endocrinol (Oxf), 50, 595, 10.1046/j.1365-2265.1999.00692.x · DOI
- Ovesen, 1998, Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women., J Clin Endocrinol Metab, 83, 1662, 10.1210/jcem.83.5.4761 · doi:10.1210/jcem.83.5.4761 · Paper page
- Bellantoni, 1996, Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study., J Clin Endocrinol Metab, 81, 2848
- Friend, 1996, Both oral and transdermal estrogen increase growth hormone release in postmenopausal women—a clinical research center study., J Clin Endocrinol Metab, 81, 2250
- Baxter, 1988, Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex., J Clin Endocrinol Metab, 67, 265, 10.1210/jcem-67-2-265 · DOI · Paper page
- Lamson, 1991, Insulin-like growth factor binding proteins: structural and molecular relationships., Growth Factors, 5, 19, 10.3109/08977199109000268 · doi:10.3109/08977199109000268
- Le Roith, 2001, The somatomedin hypothesis: 2001., Endocr Rev, 22, 53, 10.1210/edrv.22.1.0419 · DOI · Paper page
- Roelen, 1997, Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein., J Clin Endocrinol Metab, 82, 760, 10.1210/jcem.82.3.3836 · DOI
- Buijs, 2003, Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism., Am J Clin Nutr, 77, 544, 10.1093/ajcn/77.3.544 · DOI
- Pijl, 2001, Altered neuroregulation of GH secretion in viscerally obese premenopausal women., J Clin Endocrinol Metab, 86, 5509, 10.1210/jcem.86.11.8061 · doi:10.1210/jcem.86.11.8061 · Paper page
- Weltman, 2003, Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults., Metabolism, 52, 73, 10.1053/meta.2003.50007 · DOI
- Miller, 2005, Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk., J Clin Endocrinol Metab, 90, 768, 10.1210/jc.2004-0894 · DOI · Paper page
Cited by
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
The intricate role of growth hormone in metabolism
Vijayakumar, A., Yakar, S., & LeRoith, D. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00032 · Cited by 179
Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity
Brick, D. J., Gerweck, A. V., Meenaghan, E., Lawson, E. A., Misra, M., Fazeli, P., Johnson, W., Klibanski, A., & Miller, K. K. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0365 · Cited by 46
Self-citation
Metadata
- Authors
- Utz, A. L., Yamamoto, A., Sluss, P., Breu, J., & Miller, K. K.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-10-01
- Volume
- 93
- Issue
- 10
- Pages
- 4033-4040
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2095967997
- Cited by
- 37
- References
- 10
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.